Season 2, Episode 10

Creating the Ecosystem and Infrastructure for Digital Pathology

This episode's guest:

Michael Valante

This episode of Digital Pathology Today™ our guest is Michael Valante - Global Business Development Leader - Healthcare UDS & Chief Technology Officer - Digital Pathology, Dell.

We discuss lessons learned from Dell’s involvement in IT infrastructure throughout healthcare and disciplines outside of pathology. Digital Pathology, as a field is, moving incredibly fast. It seems like we’ve hit an inflection point in the past year. We’ll discuss the trajectory and the velocity of the digital transformation.

Pathology certainly has different stakeholders – lab managers, hospital administrators, IT staff, the pathologists, other physicians. Roughly what are the concerns of each of these varied groups of stakeholders? And what is Dell’s approach to balancing both the technical and clinical aspects of digital pathology?


More About Michael Valante

Mike Valante - Global Business Development Leader - Healthcare UDS & Chief Technology Officer - Digital Pathology, Dell

Michael is the global business leader for Dell Technologies Unstructured Data Solutions Healthcare division. Additionally, he is Dell’s CTO for Digital Pathology where he is a subject matter expert in the areas of enterprise imaging and pathology informatics.

Mike joined the team in 2020 after 20+ years of medical informatics and IT experience with leadership positions in global healthcare technology companies including Philips, Eclipsys, First Consulting Group and Bell Laboratories. Most recently, Mike was a Director in Philips Precision Diagnostics business where he led the Marketing and Market support teams for enterprise imaging, PACS and advanced visualization. Prior to this, he was the head of global marketing and sales support for Philips Digital and Computational Pathology business where he led the introduction of several innovations in whole slide imaging and the commercial introduction of the first digital pathology solution approved by the FDA for primary diagnosis.

He is deeply focused on the healthcare industry and the intersection of medical imaging and information technology. Improved outcomes, clinical efficiency, high performance computing and data-at-scale have figured prominently throughout Mike’s career. This, combined with a background in biomedical engineering, enables him to provide a strategic linkage between clinical requirements and technical capabilities. With data analytics playing an ever-increasing role in healthcare and precision medicine, Mike strives to deliver a customer-enabling vision for leveraging technology to achieve organizational objectives and improve care.